Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia

clinicaltrials.gov/study/NCT00209456

Is a

‌

Clinical study

Clinical Study attributes

NCT Number

NCT002094560

Health Conditions in Trial

‌

Vascular dementia

Trial Recruitment Size

3260

Trial Sponsor

GE Healthcare

Clinical Trial Start Date

2003

Clinical Trial Study Type

Interventional0

Interventional Trial Purpose

Diagnostic0

Interventional Trial Phase

Phase 30

Official Name

GEHC Has Decided Not to Provide This Detail But Will Rely on the Brief Title0

Last Updated

May 16, 2007

Allocation Type

Non-Randomized0

Intervention Model

Single Group Assignment0

Masking Type

None (Open Label)0

Study summary

The study is designed to determine the diagnostic efficacy of the visual assessment of SPECT scans in differentiating between probable dementia with Lewy Bodies (DLB) and non-DLB dementia subjects determined by the clinical diagnosis of an independent expert consensus panel used as the standard of truth.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia

Contents

Clinical Study attributes

Timeline

Further Resources

References

Find more entities like Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia